The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kenis V.M.

The Turner Scientific Research Institute for Children’s Orthopedics, Saint-Petersburg, Russia

Ivanov S.V.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Kiseleva T.I.

Stepanova Yu.A.

A.V. Vishnevsky Institute of Surgery, Ministry of Health of the Russian Federation, Moscow

Repetitive botulinum toxine injections in children with cerebral palsy: causes of parents' decline and the ways to resolve

Authors:

Kenis V.M., Ivanov S.V., Kiseleva T.I., Stepanova Yu.A.

More about the authors

Read: 2520 times


To cite this article:

Kenis VM, Ivanov SV, Kiseleva TI, Stepanova YuA. Repetitive botulinum toxine injections in children with cerebral palsy: causes of parents' decline and the ways to resolve. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(12):40‑43. (In Russ.)

Recommended articles:
Expe­rience of Rela­tox (botulinum toxin type A) using for chro­nic migraine treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):134-140
Complex balneotherapy at the stage of spa treatment of children with cere­bral palsy. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):29-37
Modern concepts of the blood supply to the frontalis muscle: anatomy, clinical aspe­cts, and significance. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(4):60-67
The use of botu­linum toxin in ventral hernia repair. Endo­scopic Surgery. 2026;(1):68-73

References:

  1. Kenis V.M. Primenenie botulotoksinov v kompleksnom lechenii detei s DTsP. Mater. XI Ros. Nats. Kongress "Chelovek i ego zdorov'e". St-Peterburg, 23 noyabrya 2006 g. Sb. "Chelovek i zdorov'e". St-Peterburg 2006.
  2. Umnov V.V., Kenis V.M. Sovremennye podkhody k lecheniyu lokal'noi spastichnosti u detei s tserebral'nym paralichom. Mater. nauch.-prakt. konf. detskikh travmatologov-ortopedov Rossii, 19-21 sent. 2007. Ekaterinburg 2007; 282-284.
  3. Boyd R., Graham H.K. Botulinum toxin A in the management of children with cerebral palsy: indications and outcome. Eur J Neurol 1997; 4: 15-22.
  4. Crowner B.E., Brunstrom J.E., Racette B.A. Iatrogenic botulism due to therapeutic Botulinum toxin A injection in a pediatric patient. Clin Neuropharmacol 2007; 30: 310-313.
  5. Koman L.A., Mooney J.F., Smith B.P. et al. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediat Orthoped 1994; 14: 299-303.
  6. Lawrence I, Moy R. An Evaluation of Neutralizing Antibody Induction During Treatment of Glabellar Lines with a New US Formulation of Botulinum Neurotoxin Type A. Aesthetic Surgery Journal 2009; 29: 6: 66-71.
  7. Molenaers G., Schorkhuber V., Fagard K. et al. Long-term use of botulinum toxin type A in children with cerebral palsy: Treatment consistency. Eur J Paediat Neurol 2008; 13: 421-429.
  8. Naidu K., Smith K., Sheedy M. et al. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy Dev Med Child Neurol 2010; 52: 139-144.
  9. Rosenbaum P.L., Palisano R.J., Bartlett D.J. et al. Development of the Gross Motor Function Classification System for cerebral palsy. Dev Med Child Neurol 2008; 50: 249-253.
  10. Saraph V., Zwick E.B., Steinwender C. et al. Conservative management of dynamic equinus in diplegic children treated by gait improvement surgery. J Pediat Orthoped 2001; 10: 287-292.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.